Shareholders Equity: The sum of preferred and common equity items.
Verrica Pharmaceuticals Inc. (VRCA) had Shareholders Equity of $24.74M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$35.58M |
|
$-17.89M |
|
$3.44M |
|
$32.14M |
|
$47.76M |
|
$-12.19M |
|
$-5.70M |
|
$-17.89M |
|
$-17.89M |
|
$-17.89M |
|
$-17.89M |
|
$-17.89M |
|
$-17.89M |
|
$-12.19M |
|
$-11.40M |
|
10.65M |
|
10.65M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$42.54M |
|
$0.21M |
|
$4.59M |
|
$47.13M |
|
$16.44M |
|
$0.64M |
|
$5.95M |
|
$22.39M |
|
$24.74M |
|
$24.74M |
|
|
Shareholders Equity |
$24.74M |
17.18M |
|
| Cash Flow Statement Financials | |
$-17.63M |
|
$0.00M |
|
$1.45M |
|
$46.33M |
|
$30.15M |
|
$-16.18M |
|
$3.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.59 |
|
-- |
|
-- |
|
0.03 |
|
0.04 |
|
90.33% |
|
-34.25% |
|
-34.25% |
|
-32.05% |
|
-50.27% |
|
-50.27% |
|
$-17.63M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
1.54 |
|
6.59 |
|
55.37 |
|
-72.29% |
|
-72.29% |
|
-37.95% |
|
-70.46% |
|
$1.44 |
|
$-1.65 |
|
$-1.65 |
|